Results 161 to 170 of about 9,329 (213)
Some of the next articles are maybe not open access.

Flucytosine

Annals of Internal Medicine, 1977
Flucytosine is a systemic antifungal drug that is readily absorbed from the gastrointestinal tract. The most clearly documented therapeutic effect has been in cryptococcosis, candidiasis, and chromomycosis. An important limitation of the use of flucytosine in all three diseases has been drug resistance arising during therapy.
openaire   +2 more sources

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

open access: yesNew England Journal of Medicine, 1979
We compared amphotericin B therapy for cryptococcal meningitis with a newer regimen containing both amphotericin B and flucytosine. In 50 patients with 51 courses of therapy adherent to the protocol, 27 courses were with amphotericin B and 24 with the ...
John E Bennett   +2 more
exaly   +3 more sources

Flucytosine

Archives of Dermatology, 1974
Orally administered flucytosine appeared to successfully eradicate chromomycosis in three patients. The duration of therapy should be adequate for complete clinical and mycological evidence of cure. Flucytosine is easily administered and the untoward effects are minor, infrequent, and easily reversible.
openaire   +1 more source

Flucytosine

2003
Abstract Flucytosine (5-fluorocytosine; 5-flucytosine; 5-FC) is one of the oldest antifungal agents in use (Utz, 1972). It was initially synthesized in 1957, but was not discovered to possess significant antifungal properties until 1964, when activity against Cryptococcus neoformans and Candida species was shown (Grunmberg et al, 1964 ...
openaire   +1 more source

Error in Flucytosine Dosage?

Annals of Internal Medicine, 1973
Excerpt To the editor: There is a potentially serious error in the package insert for the new antifungal agent, flucytosine.
openaire   +2 more sources

Flucytosine

Reactions Weekly, 2021
openaire   +2 more sources

Flucytosine (5-fluorocytosine)

Clinics in Laboratory Medicine, 1987
Monitoring of flucytosine (5-FC) concentration in serum is of great importance. It may be anticipated that demand for this service will increase in the near future, because this drug is used in situations involving immunocompromised patients, including those afflicted with AIDS.
openaire   +2 more sources

Flucytosine

New England Journal of Medicine, 1972
openaire   +2 more sources

Home - About - Disclaimer - Privacy